You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Details for New Drug Application (NDA): 205030

✉ Email this page to a colleague

« Back to Dashboard

NDA 205030 describes BLEOMYCIN SULFATE, which is a drug marketed by Cipla, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Teva Parenteral, and Teva Pharms Usa, and is included in eight NDAs. It is available from five suppliers. Additional details are available on the BLEOMYCIN SULFATE profile page.

The generic ingredient in BLEOMYCIN SULFATE is bleomycin sulfate. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.

Summary for 205030

Tradename:	BLEOMYCIN SULFATE
Applicant:	Meitheal
Ingredient:	bleomycin sulfate
Patents:	0

Pharmacology for NDA: 205030

Medical Subject Heading (MeSH) Categories for 205030

Antibiotics, Antineoplastic

Suppliers and Packaging for NDA: 205030

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
BLEOMYCIN SULFATE	bleomycin sulfate	INJECTABLE;INJECTION	205030	ANDA	NorthStar Rx LLC	16714-886	16714-886-01	1 VIAL, SINGLE-DOSE in 1 CARTON (16714-886-01) / 15 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
BLEOMYCIN SULFATE	bleomycin sulfate	INJECTABLE;INJECTION	205030	ANDA	NorthStar Rx LLC	16714-908	16714-908-01	1 VIAL, SINGLE-DOSE in 1 CARTON (16714-908-01) / 30 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	EQ 15 UNITS BASE/VIAL
Approval Date:	Apr 20, 2018	TE:	AP	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	EQ 30 UNITS BASE/VIAL
Approval Date:	Apr 20, 2018	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.